ARMILA, UAB - financials and debts

Company age: 29 y. 9 mo.

Update

ARMILA - Company finances

EUR
2018
From: 2017-09-01
To: 2018-08-31
2019
From: 2018-09-01
To: 2019-08-31
2020
From: 2019-09-01
To: 2020-08-31
2021
From: 2020-09-01
To: 2021-08-31
2022
From: 2021-09-01
To: 2022-09-30
2023
From: 2022-10-01
To: 2023-09-30
2024
From: 2023-10-01
To: 2024-09-30
2025
From: 2024-10-01
To: 2025-09-30
Financial data
Sales revenue 58,739,000 72,405,000 77,932,000 74,788,000 84,842,000 92,402,000 101,903,000 116,199,000
Profit before tax 1,434,000 1,655,000 2,364,000 2,176,000 2,761,000 1,726,000 2,621,000 2,566,000
Net profit - - - - 2,286,000 1,252,000 2,254,000 2,142,000
Equity 15,738,000 16,839,000 18,828,000 20,652,000 22,938,000 24,190,000 26,444,000 28,586,000
Liabilities - - - - 7,053,000 9,302,000 11,809,000 13,129,000
Non-current assets 1,655,000 1,519,000 4,089,000 3,683,000 3,334,000 3,095,000 3,012,000 2,626,000
Current assets 19,646,000 22,733,000 25,538,000 25,276,000 26,657,000 30,397,000 35,241,000 39,089,000
Total assets 21,301,000 24,252,000 29,627,000 28,959,000 29,991,000 33,492,000 38,253,000 41,715,000
Taxes paid
STI taxes - - - - - 3,819,597 4,358,920 4,175,273
Social insurance contributions - - - - - 521,020 562,071 641,544
Financial indicators
Revenue change y/y -27.1% +23.3% +7.6% -4.0% +13.4% +8.9% +10.3% +14.0%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. - - - - 7.6% 3.7% 5.9% 5.1%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - - - 10.0% 5.2% 8.5% 7.5%
Profit margin Net profit margin. Shows the overall profitability of the company. - - - - 2.7% 1.4% 2.2% 1.8%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 2.4% 2.3% 3.0% 2.9% 3.3% 1.9% 2.6% 2.2%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - - - 0.3 0.4 0.4 0.5
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 685,669 777,155 868,323 844,267 953,281 1,033,386 1,129,119 1,222,076

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Consolidated ARMILA finance

EUR
2022
From: 2021-09-01
To: 2022-09-30
2023
From: 2022-10-01
To: 2023-09-30
2024
From: 2023-10-01
To: 2024-09-30
2025
From: 2024-10-01
To: 2025-09-30
Financial data
Sales revenue 87,424,000 94,880,000 104,171,000 118,956,000
Profit before tax 3,027,000 2,797,000 2,197,000 2,345,000
Net profit 2,549,000 2,326,000 1,845,000 1,915,000
Equity 22,218,000 24,544,000 26,389,000 28,304,000
Liabilities 7,973,000 10,095,000 12,861,000 13,998,000
Non-current assets 3,876,000 3,685,000 3,729,000 3,212,000
Current assets 26,315,000 30,954,000 35,521,000 39,090,000
Total assets 30,191,000 34,639,000 39,250,000 42,302,000

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

ARMILA - Social security debts

The company had no debts to Sodra

ARMILA - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
ARMILA, UAB (code 123813957) is a private limited liability company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated €116.20M in revenue, up 14.0% year on year and 25.8% over two years, showing steady scale expansion. Net profit in 2025 was €2.14M, below the €2.25M reported in 2024 but above the €1.25M earned in 2023. The profit margin was 1.8% in 2025, compared with 2.2% in 2024 and 1.4% in 2023, indicating that profitability remained positive but thin relative to turnover. Balance sheet strength remained solid: total assets reached €41.72M, equity €28.59M and liabilities €13.13M. The equity ratio stood at 68.5%, and debt-to-equity was 0.46, pointing to a conservative capital structure. Asset turnover was 2.79x, while return on equity was 7.5% and return on assets 5.1%. Revenue per employee was €1.22M, with profit per employee at €22.5K.